COAGULOPATHY
Clinical trials for COAGULOPATHY explained in plain language.
Never miss a new study
Get alerted when new COAGULOPATHY trials appear
Sign up with your email to follow new studies for COAGULOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breakthrough drug trial aims to stop deadly blood clots in ICU patients
Disease control Not yet recruitingThis study is testing whether a drug called sivelestat can help restore normal blood clotting in ICU patients with septic shock who develop dangerous blood clotting problems. The trial will involve 120 patients who will receive either the drug or a placebo to see if sivelestat im…
Matched conditions: COAGULOPATHY
Phase: PHASE2 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Can a computer read your blood clot test as well as a doctor?
Diagnosis Not yet recruitingThis study aims to see if an artificial intelligence (AI) system can interpret a specialized blood clotting test as consistently as expert doctors do. Researchers will collect 400 blood test results from critically ill or surgical patients. They will compare the AI's readings and…
Matched conditions: COAGULOPATHY
Sponsor: Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s. • Aim: Diagnosis
Last updated Apr 02, 2026 03:42 UTC